| “It’s too hard”–the management of latent TB in under-served populations in the UK: a qualitative study AT Gray, J Surey, H Esmail, A Story, M Harris BMC health services research 22 (1), 1464, 2022 | 3 | 2022 |
| A global core outcome measurement set for snakebite clinical trials M Abouyannis, H Esmail, M Hamaluba, M Ngama, H Mwangudzah, ... The Lancet Global Health 11 (2), e296-e300, 2023 | 13 | 2023 |
| A threat to decentralised care for drug-resistant tuberculosis AT Gray, T Boyles, S Luedtke, B Sossen, G Birjovanu, P Kostkova, ... The Lancet Respiratory Medicine 8 (10), 950-952, 2020 | 7 | 2020 |
| A27 HIV AND THE LUNG: Characterisation Of A Whole Blood Transcriptional Signature Of Subclinical Tuberculosis Identified By Fdg-Pet/ct In Asymptomatic Hiv-1 Infected Adults H Esmail, RP Lai, CM Graham, T Oni, N Bangani, JM Warwick, ... American Journal of Respiratory and Critical Care Medicine 189, 1, 2014 | | 2014 |
| Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings NM Noor, SL Pett, H Esmail, AM Crook, CL Vale, MR Sydes, MKB Parmar F1000Research 9, 2020 | 19 | 2020 |
| Anti-inflammatory therapy with nebulised dornase alfa for severe COVID-19 pneumonia JC Porter, J Inshaw, VJ Solis, E Denneny, R Evans, MI Temkin, ... eLife 12, 2024 | | 2024 |
| Anti-inflammatory therapy with nebulised dornase alfa in patients with severe COVID-19 pneumonia JC Porter, J Inshaw, VJ Solis, E Denneny, R Evans, MI Temkin, ... medRxiv, 2022.04. 14.22272888, 2022 | 3 | 2022 |
| Anti-inflammatory therapy with nebulised dornase alfa in patients with severe COVID-19 pneumonia (preprint) J Porter, J Inshaw, VJ Solis, E Denneny, R Evans, MI Temkin, ... | | 2022 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 227 | 2022 |
| Before the whistle blows: developing new paradigms in tuberculosis screening to maximise benefit and minimise harm P MacPherson, CM Williams, RM Burke, MR Barer, H Esmail Wellcome Open Research 6, 8, 2021 | | 2021 |
| Beyond latent and active tuberculosis: a scoping review of conceptual frameworks SMA Zaidi, AK Coussens, JA Seddon, T Kredo, D Warner, RMGJ Houben, ... Eclinicalmedicine, 2023 | 3 | 2023 |
| Beyond latent and active: a scoping review of conceptual frameworks and diagnostic criteria for tuberculosis SMA Zaidi, A Coussens, T Kredo, J Seddon, D Warner, RMGJ Houben, ... medRxiv, 2023.07. 05.23292171, 2023 | | 2023 |
| Cardio-thoracic ratio is stable, reproducible and has potential as a screening tool for HIV-1 related cardiac disorders in resource poor settings H Esmail, T Oni, F Thienemann, N Omar-Davies, RJ Wilkinson, M Ntsekhe PloS one 11 (10), e0163490, 2016 | 9 | 2016 |
| Characterisation Of A Whole Blood Transcriptional Signature Of Subclinical Tuberculosis Identified By FDG-PET/CT In Asymptomatic HIV-1 Infected Adults H Esmail, RP Lai, CM Graham, T Oni, N Bangani, JM Warwick, ... A27. HIV AND THE LUNG, A6573-A6573, 2014 | | 2014 |
| Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography H Esmail, RP Lai, M Lesosky, KA Wilkinson, CM Graham, AK Coussens, ... Nature medicine 22 (10), 1090-1093, 2016 | 185 | 2016 |
| Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F] fluoro-ᴅ-glucose positron emission and computed tomography H Esmail, RP Lai, M Lesosky, KA Wilkinson, CM Graham, AK Coussens, ... The Francis Crick Institute, 2016 | | 2016 |
| Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise AK Coussens, SMA Zaidi, BW Allwood, PK Dewan, G Gray, M Kohli, ... The Lancet Respiratory Medicine, 2024 | 2 | 2024 |
| Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review M Abouyannis, D Aggarwal, DG Lalloo, NR Casewell, M Hamaluba, ... PLoS Neglected Tropical Diseases 15 (8), e0009589, 2021 | 19 | 2021 |
| Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently IR White, B Choodari-Oskooei, MR Sydes, BC Kahan, L McCabe, ... Clinical Trials 19 (4), 432-441, 2022 | 5 | 2022 |
| Communicable and non-communicable co-morbidities and the presentation of COVID-19 in an African setting of high HIV-1 and tuberculosis prevalence E du Bruyn, C Stek, R Daroowala, Q Said-Hartley, M Hsiao, RT Goliath, ... medRxiv, 2021.05. 11.21256479, 2021 | 4 | 2021 |
Ruth R MillerCanexia Health在 canexiahealth.com 的电子邮件经过验证
Ruth R MillerCanexia Health在 canexiahealth.com 的电子邮件经过验证